Deerfield Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,127,270
| Closed | -$80.7M | – | 588 |
|
|
2024
Q1 | $80.7M | Sell |
5,127,270
-660,754
| -11% | -$10.4M | 1.4% | 22 |
|
|
2023
Q4 | $93.4M | Sell |
5,788,024
-1,109,582
| -16% | -$17.9M | 1.72% | 17 |
|
|
2023
Q3 | $87.7M | Buy |
6,897,606
+190,580
| +3% | +$2.42M | 1.93% | 17 |
|
|
2023
Q2 | $94.4M | Buy |
6,707,026
+1,488,388
| +29% | +$21M | 2.02% | 14 |
|
|
2023
Q1 | $80.6M | Buy |
5,218,638
+2,869,410
| +122% | +$44.3M | 1.8% | 16 |
|
|
2022
Q4 | $38.5M | Sell |
2,349,228
-142,262
| -6% | -$2.33M | 0.8% | 38 |
|
|
2022
Q3 | $46.1M | Sell |
2,491,490
-3,759,474
| -60% | -$69.6M | 0.92% | 35 |
|
|
2022
Q2 | $82.2M | Buy |
6,250,964
+670,508
| +12% | +$8.82M | 1.7% | 17 |
|
|
2022
Q1 | $51.7M | Hold |
5,580,456
| – | – | 1.16% | 27 |
|
|
2021
Q4 | $54.5M | Buy |
5,580,456
+4,765,456
| +585% | +$46.6M | 1.14% | 27 |
|
|
2021
Q3 | $27.7M | Sell |
815,000
-528,560
| -39% | -$18M | 0.54% | 53 |
|
|
2021
Q2 | $49.2M | Buy |
1,343,560
+814,975
| +154% | +$29.8M | 0.87% | 36 |
|
|
2021
Q1 | $23.7M | Hold |
528,585
| – | – | 0.5% | 69 |
|
|
2020
Q4 | $30.2M | Hold |
528,585
| – | – | 0.6% | 52 |
|
|
2020
Q3 | $27.1M | Buy |
528,585
+106,906
| +25% | +$5.48M | 0.66% | 49 |
|
|
2020
Q2 | $25.2M | Sell |
421,679
-167,806
| -28% | -$10M | 0.73% | 42 |
|
|
2020
Q1 | $24.3M | Buy |
589,485
+281,485
| +91% | +$11.6M | 0.77% | 39 |
|
|
2019
Q4 | $19.2M | Sell |
308,000
-286,725
| -48% | -$17.8M | 0.61% | 52 |
|
|
2019
Q3 | $20.2M | Sell |
594,725
-12,908
| -2% | -$438K | 0.82% | 40 |
|
|
2019
Q2 | $13.7M | Hold |
607,633
| – | – | 0.49% | 63 |
|
|
2019
Q1 | $14.1M | Hold |
607,633
| – | – | 0.54% | 52 |
|
|
2018
Q4 | $12.8M | Buy |
+607,633
| New | +$12.8M | 0.51% | 54 |
|
|
2018
Q1 | – | Sell |
-336,009
| Closed | -$7.62M | – | 123 |
|
|
2017
Q4 | $7.62M | Buy |
336,009
+11,009
| +3% | +$250K | 0.3% | 75 |
|
|
2017
Q3 | $6.17M | Buy |
+325,000
| New | +$6.17M | 0.28% | 74 |
|